Copyright Reports & Markets. All rights reserved.

Global Netupitant-Palonosetron FDC Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Netupitant-Palonosetron FDC Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Flakes
      • 1.4.3 Capsules
      • 1.4.4 Other
    • 1.5 Market by Application
      • 1.5.1 Global Netupitant-Palonosetron FDC Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacy
      • 1.5.3 Drug Stores
      • 1.5.4 Retail Pharmacy
      • 1.5.5 Online Pharmacy
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Netupitant-Palonosetron FDC Market Size
    • 2.2 Netupitant-Palonosetron FDC Growth Trends by Regions
      • 2.2.1 Netupitant-Palonosetron FDC Market Size by Regions (2014-2025)
      • 2.2.2 Netupitant-Palonosetron FDC Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Netupitant-Palonosetron FDC Market Size by Manufacturers
      • 3.1.1 Global Netupitant-Palonosetron FDC Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Netupitant-Palonosetron FDC Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Netupitant-Palonosetron FDC Market Concentration Ratio (CR5 and HHI)
    • 3.2 Netupitant-Palonosetron FDC Key Players Head office and Area Served
    • 3.3 Key Players Netupitant-Palonosetron FDC Product/Solution/Service
    • 3.4 Date of Enter into Netupitant-Palonosetron FDC Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Netupitant-Palonosetron FDC Market Size by Type (2014-2019)
    • 4.2 Global Netupitant-Palonosetron FDC Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Netupitant-Palonosetron FDC Market Size (2014-2019)
    • 5.2 Netupitant-Palonosetron FDC Key Players in United States
    • 5.3 United States Netupitant-Palonosetron FDC Market Size by Type
    • 5.4 United States Netupitant-Palonosetron FDC Market Size by Application

    6 Europe

    • 6.1 Europe Netupitant-Palonosetron FDC Market Size (2014-2019)
    • 6.2 Netupitant-Palonosetron FDC Key Players in Europe
    • 6.3 Europe Netupitant-Palonosetron FDC Market Size by Type
    • 6.4 Europe Netupitant-Palonosetron FDC Market Size by Application

    7 China

    • 7.1 China Netupitant-Palonosetron FDC Market Size (2014-2019)
    • 7.2 Netupitant-Palonosetron FDC Key Players in China
    • 7.3 China Netupitant-Palonosetron FDC Market Size by Type
    • 7.4 China Netupitant-Palonosetron FDC Market Size by Application

    8 Japan

    • 8.1 Japan Netupitant-Palonosetron FDC Market Size (2014-2019)
    • 8.2 Netupitant-Palonosetron FDC Key Players in Japan
    • 8.3 Japan Netupitant-Palonosetron FDC Market Size by Type
    • 8.4 Japan Netupitant-Palonosetron FDC Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Netupitant-Palonosetron FDC Market Size (2014-2019)
    • 9.2 Netupitant-Palonosetron FDC Key Players in Southeast Asia
    • 9.3 Southeast Asia Netupitant-Palonosetron FDC Market Size by Type
    • 9.4 Southeast Asia Netupitant-Palonosetron FDC Market Size by Application

    10 India

    • 10.1 India Netupitant-Palonosetron FDC Market Size (2014-2019)
    • 10.2 Netupitant-Palonosetron FDC Key Players in India
    • 10.3 India Netupitant-Palonosetron FDC Market Size by Type
    • 10.4 India Netupitant-Palonosetron FDC Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Netupitant-Palonosetron FDC Market Size (2014-2019)
    • 11.2 Netupitant-Palonosetron FDC Key Players in Central & South America
    • 11.3 Central & South America Netupitant-Palonosetron FDC Market Size by Type
    • 11.4 Central & South America Netupitant-Palonosetron FDC Market Size by Application

    12 International Players Profiles

    • 12.1 Eisai Pharmaceutical
      • 12.1.1 Eisai Pharmaceutical Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Netupitant-Palonosetron FDC Introduction
      • 12.1.4 Eisai Pharmaceutical Revenue in Netupitant-Palonosetron FDC Business (2014-2019)
      • 12.1.5 Eisai Pharmaceutical Recent Development
    • 12.2 Helsinn
      • 12.2.1 Helsinn Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Netupitant-Palonosetron FDC Introduction
      • 12.2.4 Helsinn Revenue in Netupitant-Palonosetron FDC Business (2014-2019)
      • 12.2.5 Helsinn Recent Development
    • 12.3 Heron Therapeutics
      • 12.3.1 Heron Therapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Netupitant-Palonosetron FDC Introduction
      • 12.3.4 Heron Therapeutics Revenue in Netupitant-Palonosetron FDC Business (2014-2019)
      • 12.3.5 Heron Therapeutics Recent Development
    • 12.4 Tesaro
      • 12.4.1 Tesaro Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Netupitant-Palonosetron FDC Introduction
      • 12.4.4 Tesaro Revenue in Netupitant-Palonosetron FDC Business (2014-2019)
      • 12.4.5 Tesaro Recent Development
    • 12.5 Acacia Pharma
      • 12.5.1 Acacia Pharma Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Netupitant-Palonosetron FDC Introduction
      • 12.5.4 Acacia Pharma Revenue in Netupitant-Palonosetron FDC Business (2014-2019)
      • 12.5.5 Acacia Pharma Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      The netupitant-palonosetron FDC is an oral therapy that targets two critical pathways associated with acute and delayed CINV by blockage of P/NK1 receptors. Netupitant in the central nervous system inhibits the binding of endogenous tachykinin neuropeptide substance, which prevents chemotherapy-induced nausea and vomiting (CINV).
      Presently, patient pool segment has witnessed large-scale adoption of netupitant-palonosetron FDC drugs due to rise in number of patient undergoing chemotherapy.
      North America was the dominant regional market for netupitant‐palonosetron FDC drugs, in terms of revenue, due to growth in incidence of CINV among patients.
      In 2018, the global Netupitant-Palonosetron FDC market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Netupitant-Palonosetron FDC status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Netupitant-Palonosetron FDC development in United States, Europe and China.

      The key players covered in this study
      Eisai Pharmaceutical
      Helsinn
      Heron Therapeutics
      Tesaro
      Acacia Pharma
      ...

      Market segment by Type, the product can be split into
      Flakes
      Capsules
      Other

      Market segment by Application, split into
      Hospital Pharmacy
      Drug Stores
      Retail Pharmacy
      Online Pharmacy

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Netupitant-Palonosetron FDC status, future forecast, growth opportunity, key market and key players.
      To present the Netupitant-Palonosetron FDC development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Netupitant-Palonosetron FDC are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now